Effect of cabozantinib treatment on circulating immune cell populations in patients with metastatic triple-negative breast cancer (TNBC).
Duda D, Ziehr D, Guo H, Ng M, Barry W, Higgins M, Isakoff S, Brock J, Ivanova E, Paweletz C, Demeo M, Ramaiya N, Overmoyer B, Jain R, Winer E, Tolaney S. Effect of cabozantinib treatment on circulating immune cell populations in patients with metastatic triple-negative breast cancer (TNBC). Journal Of Clinical Oncology 2016, 34: 1093-1093. DOI: 10.1200/jco.2016.34.15_suppl.1093.Peer-Reviewed Original Research